From: Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer
index
Type number
Benefit number
Benefit percent
P (< 0.05)
Patient type
Triploid
16
4
25%
0.048
Non-triploid
63
54
85.71%